Contents

03 May 2017
Vol 9, Issue 388

About The Cover

Cover image expansion

ONLINE COVER Antibodies for All. Respiratory syncytial virus (RSV) can be lethal to the immunocompromised individuals, including infants. No vaccine exists, and the commercially available monoclonal antibody is only given in high risk situations. Zhu et al. have now developed a broadly neutralizing anti-RSV antibody that could be given to all infants at the start of RSV season and is likely to maintain protection for several months. Wide deployment of this prophylactic antibody could reduce hospitalizations and deaths caused by this common but potentially dangerous virus. [CREDIT: IPG GUTENBERG UK LTD/ISTOCKPHOTO]